Beruflich Dokumente
Kultur Dokumente
ARENTFOX.COM
Related Practices
International Trade
Communications,
Technology & Mobile
Complex Litigation
Health Care
Intellectual Property
Related Industries
Key Contacts
James Ravitz
Partner, Practice Group Leader
james.ravitz@arentfox.com
Wayne Matelski
Partner
wayne.matelski@arentfox.com
Stephanie Trunk
Partner
stephanie.trunk@arentfox.com
Product Development
Brian Waldman
Our Food and Drug attorneys are experienced in shepherding drugs and biologics through the FDA
Partner
and, if relevant, the Drug Enforcement Agency (DEA) scheduling process, or, in the case of animal
brian.waldman@arentfox.com
health products, the US Department of Agriculture (USDA) or US Environmental Protection Agency
(EPA), when applicable. This work involves:
Naomi Halpern
Reviewing clinical research protocols and Assisting with clinical trial contracts and Counsel
related research and license agreements. reporting issues, including clinical trial audit naomi.halpern@arentfox.com
agreements.
Advising on, and filing, Investigational
Brian Malkin
New Drug Applications (INDs), New Drug Advising on FDA pre-market approval
Counsel
Applications (NDAs), 505(b)(2) NDAs , inspections.
brian.malkin@arentfox.com
New Animal Drug Applications (NADAs),
Performing domestic and foreign inspection
Abbreviated NDAs (ANDAs) and Abbreviated
audits. Emily Leongini
NADAS (ANADAs), Biologic Licensing
Associate
Applications (BLAs) for biologics, including Representing companies before the FDA
emily.leongini@arentfox.com
the new biosimilar 351(k) BLAs. to resolve outstanding issues and expedite
product approval.
Filing amendments or supplements to the
above applications. Preparing clients for FDA Advisory Committee
meetings.
Post-Market Regulatory
Our clients also turn to us for with a wide range of regulatory concerns that may arise once their
pharmaceutical products have been introduced to the market. This work includes: